Original Articles

Effect of progesterone as maintenance tocolytic therapy on the prevention of recurrent preterm labor: a randomized clinical trial

Abstract

Objective: The study evaluated the efficacy and safety of vaginal rogesterone on prevention of recurrent preterm labor.
Materials and methods: Total number of 70 patients with preterm labor treated with intravenous magnesium sulfate in perinatology department of valiasr hospital entered to a randomized clinical trial. Treatment group after inhibition of preterm labor with magnesium sulfate received progesterone suppository (400 mg) daily until delivery and control group received no treatment. Latency until delivery, recurrence of preterm labor and neonatal outcomes were studied. Statistical significance was defined as p< 0.05.
Results: Mean latency until delivery (p< 0.05), low birth weight (p< 0.05), birth weight (p< 0.01) were significantly different between the two groups. Recurrence of preterm labor was not significantly different between the groups.
Conclusions: The use of vaginal progesterone suppository after successful parenteral tocolysis associated with a longer latency preceding delivery but failed to reduce the incidence of recurrent preterm labor.

-Berkowitz GS, Papiernik E. Epidemiology of preterm births. Epidemiol Rev 1993; 15(2): 414-443.

-Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996; 175(4 Pt 1): 838-842.

-Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. The efficacy of maintenance therapy after acute tocolysis: meta- analysis. Am J Obstet Gynecol 1999; 181(2): 484-490.

-Thornton JG. Maintenance tocolysis. BJOG 2005 ; 112( Suppl 1): 118-121.

-Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al.Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. New England Journal of Medicine 2003; 348(24): 2379-2385.

-da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. American Journal of Obstetrics & Gynecology 2003; 188(2): 419-424.

-How HY, Hughes SA, Vogel RL, Gall SA, Spinnato JA. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 1995; 173: 1518-1522.

-Siiteri PK, Serón-Ferré M. Some new thoughts on the feto-placental unit and parturition in primates. In: Novy MJ, Resko JA, eds. Fetal endocrinology. New York: Academic Press, 1981: 1-34.

-Garfield RE, Kannan MS, Daniel EE. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980; 238: 81-89.

-Challis JRG. Sharp increases in free circulating oestrogens immediately before parturition in sheep. Nature 1971; 229: 208-208.

-Mitchell B, Cruickshank B, McLean D, Challis J. Local modulation of progesterone production in human fetal membranes. J Clin Endocrinol Metab 1982; 55: 1237-1239.

Files
IssueVol 1, No 1 (September 2007) QRcode
SectionOriginal Articles
Keywords
preterm labor maintenance tocolytic therapy progesterone suppository

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Borna H, Borna S, Khazardoust S, Hantoushzadeh S, Sahabi N. Effect of progesterone as maintenance tocolytic therapy on the prevention of recurrent preterm labor: a randomized clinical trial. J Family Reprod Health. 2007;1(1):12-17.